608 related articles for article (PubMed ID: 16621226)
41. Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine.
McKay C; Hall AB; Cortes J
J Neurosci Nurs; 2015 Dec; 47(6):327-32. PubMed ID: 26528950
[TBL] [Abstract][Full Text] [Related]
42. Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia.
Shi DD; Yang FZ; Zhou L; Wang N
J Clin Pharm Ther; 2016 Dec; 41(6):657-661. PubMed ID: 27578562
[TBL] [Abstract][Full Text] [Related]
43. The Control of Hypertension In Pregnancy Study pilot trial.
Magee LA; von Dadelszen P; Chan S; Gafni A; Gruslin A; Helewa M; Hewson S; Kavuma E; Lee SK; Logan AG; McKay D; Moutquin JM; Ohlsson A; Rey E; Ross S; Singer J; Willan AR; Hannah ME;
BJOG; 2007 Jun; 114(6):770, e13-20. PubMed ID: 17516972
[TBL] [Abstract][Full Text] [Related]
44. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
[TBL] [Abstract][Full Text] [Related]
45. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Paran E; Holzberg G; Mazor M; Zmora E; Insler V
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
[TBL] [Abstract][Full Text] [Related]
46. The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.
Shawkat E; Mistry H; Chmiel C; Webster L; Chappell L; Johnstone ED; Myers JE
Pregnancy Hypertens; 2018 Jan; 11():92-98. PubMed ID: 29523282
[TBL] [Abstract][Full Text] [Related]
47. Management of the pregnant patient with chronic hypertension.
Hayashi RH
Clin Ther; 1983; 5(6):568-78. PubMed ID: 6138151
[TBL] [Abstract][Full Text] [Related]
48. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
Harper A; Murnaghan GA
Br J Obstet Gynaecol; 1991 May; 98(5):453-9. PubMed ID: 2059591
[TBL] [Abstract][Full Text] [Related]
49. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
Kilpatrick SJ; Abreo A; Greene N; Melsop K; Peterson N; Shields LE; Main EK
Am J Obstet Gynecol; 2016 Jul; 215(1):91.e1-7. PubMed ID: 26829504
[TBL] [Abstract][Full Text] [Related]
50. Hypertensive Emergencies in Pregnancy.
Olson-Chen C; Seligman NS
Crit Care Clin; 2016 Jan; 32(1):29-41. PubMed ID: 26600442
[TBL] [Abstract][Full Text] [Related]
51. Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
Wu HZ; Cheng Y; Yu D; Li JB; Jiang YF; Zhu ZN
Hypertens Pregnancy; 2022 May; 41(2):126-138. PubMed ID: 35361052
[TBL] [Abstract][Full Text] [Related]
52. Parenteral hydralazine revisited.
Powers DR; Papadakos PJ; Wallin JD
J Emerg Med; 1998; 16(2):191-6. PubMed ID: 9543400
[TBL] [Abstract][Full Text] [Related]
53. Severe labetalol overdose in an 8-month-old infant.
Thorsteinsson A; Johannesdottir A; Eiríksson H; Helgason H
Paediatr Anaesth; 2008 May; 18(5):435-8. PubMed ID: 18312512
[TBL] [Abstract][Full Text] [Related]
54. Hypertensive emergencies in pregnancy.
Vadhera RB; Simon M
Clin Obstet Gynecol; 2014 Dec; 57(4):797-805. PubMed ID: 25314092
[TBL] [Abstract][Full Text] [Related]
55. Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.
Obstet Gynecol; 2011 Dec; 118(6):1465-1468. PubMed ID: 22105295
[TBL] [Abstract][Full Text] [Related]
56. Treatment of hypertension in the inpatient setting: use of intravenous labetalol and hydralazine.
Weder AB; Erickson S
J Clin Hypertens (Greenwich); 2010 Jan; 12(1):29-33. PubMed ID: 20047627
[TBL] [Abstract][Full Text] [Related]
57. Should continuous hydralazine infusions be utilized in severe pregnancy-induced hypertension?
Kirshon B; Wasserstrum N; Cotton DB
Am J Perinatol; 1991 May; 8(3):206-8. PubMed ID: 2029282
[TBL] [Abstract][Full Text] [Related]
58. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
59. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.
Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
BJOG; 2016 Jun; 123(7):1143-51. PubMed ID: 26265372
[TBL] [Abstract][Full Text] [Related]
60. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
